HOWL: Werewolf Therapeutics, Inc. Common Stock Company Profile & Statistics

About

Werewolf Therapeutics Inc. is a biopharmaceutical company. It involved in the development of conditionally activated therapeutics engineered to stimulate the body's immune system for the treatment of cancer. Werewolf Therapeutics Inc. is based in CAMBRIDGE, Mass.

Info & Links

CEO

Daniel J. Hicklin

Headquarters

200 TALCOTT AVENUE, 2ND FLOOR
WATERTOWN, MA 02472, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

Werewolf Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

39.22M

Enterprise Value

-45.68M

Enterprise Value/EBITDA(ttm)

0.64

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

6.62

Price to Book(mrq)

0.67

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

-578.80%

Profit Margin(ttm)

-922.86%

Return on Equity(ttm)

-58.83%

Return on Invested Capital(ttm)

-59.50%

Return on Assets(ttm)

-38.45%

Income Statement

Revenue(ttm)

1.89M

Revenue Per Share(ttm)

0.04

Gross Profit(ttm)

1.89M

EBITDA(ttm)³

-71.78M

Net Income Available to Common(ttm)

-70.51M

Diluted EPS(ttm)

-1.53

Share Statistics

Beta (5Y Monthly)

0.36

52-Week Change

-86.58%

S&P 500 52-Week Change

10.59%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

44.83M

Dividend Yield

0.00%

Float⁴

35.16M

% Held by Insiders

21.10%

% Held by Institutions

64.84%

Balance Sheet

Total Cash(mrq)

111.00M

Total Cash Per Share(mrq)

2.48

Total Debt(mrq)

26.09M

Total Debt/Equity(mrq)

35.56%

Current Ratio(mrq)

7.45%

Quick Ratio(mrq)

10.10%

Book Value Per Share(mrq)

1.64

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.28

Free Cash Flow(ytd)

-56.44M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

HOWL

Werewolf Therapeutics, Inc. Common Stock

Werewolf Therapeutics, Inc. Common Stock Profile